LianBio ADR Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. LianBio ADR last-minute Real Value cannot be determined due to lack of data. The latest price of LianBio ADR is $0.0. Our model forecasts the value of LianBio ADR from analyzing the firm fundamentals such as Shares Owned By Insiders of 5.90 %, return on equity of -0.32, and Current Valuation of (182.65 M) as well as examining its technical indicators and probability of bankruptcy.
LianBio ADR Total Value Analysis
LianBio ADR is now forecasted to have valuation of (182.65 M) with market capitalization of 34.47 M, debt of 4.34 M, and cash on hands of 329.3 M. The negative valuation of LianBio ADR may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the LianBio ADR fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(182.65 M) | 34.47 M | 4.34 M | 329.3 M |
LianBio ADR Asset Utilization
One of the ways to look at asset utilization of LianBio is to check how much profit was generated for every dollar of assets it reports. LianBio ADR secures a negative usage of assets of -0.22 %, losing $0.002167 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of LianBio ADR shows how discouraging it operates for each dollar spent on its assets.LianBio ADR Ownership Allocation
LianBio ADR maintains a total of 108.06 Million outstanding shares. The majority of LianBio ADR outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in LianBio ADR to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in LianBio ADR. Please pay attention to any change in the institutional holdings of LianBio ADR as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.LianBio ADR Profitability Analysis
Net Loss for the year was (87.98 M) with profit before overhead, payroll, taxes, and interest of 0.LianBio ADR Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 107.9 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in LianBio Stock
If you are still planning to invest in LianBio ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LianBio ADR's history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |